Moreover, depletion of endogenous ADAM23 in GSCs results in increased brain infiltration and slow-growing tumors, prolonging survival in patients with astrocytoma and murine models owing to reduced cerebral herniation. The gene discussed is ADAM23; the disease is astrocytoma (excluding glioblastoma).